Moreover, several papers have shown a clear link between angiogenesis-modulatory molecules such as VEGF and basic fibroblast growth factor (bFGF) and downregulation of CAMs on tumor endothelial cells (76, 77). This evidence concerns the gene FGF2 and neoplasm.